Moffitt logo

COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More

Clinical Trials Search

Clinical Trial 21056

Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#: NCT04623541

Phase: Phase I/II
Prinicipal Investigator: Jose Sandoval-Sus

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia

Summary

Objective

Treatments

Therapies

Medications

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

;